🎉 v1.0 launch — BD Match Pro is open-source and live

[rosinmingyang-collab]

🎉 BD Match Pro v1.0 is live

After a few weeks of late-night iteration, BD Match Pro v1.0 is now public, open-source, and live online.

What it is

An AI-powered cross-border licensing engine for biopharma assets — answering the three questions every BD practitioner faces on day one of a new asset:

• Q.01 · Who would buy this?
• Q.02 · How much is it worth?
• Q.03 · How should the deal be structured?

What's in v1.0

• 🎯 380+ buyer database with portfolio, financials, recent deals, public contacts
• 🧮 rNPV valuation with every parameter user-editable in real time
• 💼 1,196 comparable transactions powering the upfront / milestone / royalty regression
• 🧬 Separate biosimilar model with biosim-specific PoS / WACC / GM / share-of-originator
• 🌐 Bilingual (中/EN) UI with stage-conditional parameter display
• 📐 Single self-contained index.html — open it in any browser, no build
• 📜 MIT licensed — fork it, sell it, embed it, modify it

Try it

→ Live tool: https://raphahealthtech.github.io/bd-match-pro/
→ Source: https://github.com/raphahealthtech/bd-match-pro
→ Release notes: https://github.com/raphahealthtech/bd-match-pro/releases/tag/v1.0.0

What we'd love from you

• ⭐ A star if you find it useful
• 🐛 Bug reports / data corrections
• 🧮 Methodology critique — we want to be wrong about specific things
• 💬 Tell us your use case in Discussions

Why open-source

Pharma BD has long been the black box of a few elite shops. We think the methodology should be debatable, the data should be community-refreshed, and Chinese biopharma assets deserve better global infrastructure to find their right buyers.

Deals are art, not models. But if AI can save practitioners a few wrong turns at the very first mile, it has already earned its keep.

— Rapha Health · 睿孚健康